Tykerb tablets 250mg from Novartis Pharma, containing Lapatinib tosylate hydrate, is a targeted therapy medication used for certain advanced or metastatic HER2-positive breast cancer cases. This 250mg x 1 tablet formulation carries YJ code 4291022F1026.
Tykerb tablets 250mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →